Dr. Sergei Kulemzin on CAR T-Cell Engineering: Design, Structure, and Cancer Treatment

In this webinar recording, Dr. Sergei delves into the crucial role of chimeric antigen receptor (CAR) structure in determining the effectiveness of cell therapy.
Discover how different CAR designs can impact:
Target recognition: How well the CAR binds to cancer cells.
T-cell activation: The strength of the immune response triggered.
Persistence: How long the engineered T-cells remain active in the body.
This deep dive into CAR structure is essential for anyone interested in the future of cancer treatment.